Copyright Reports & Markets. All rights reserved.

Global Iopamidol Injection Market Research Report 2021

Request for Sample of this report
Buy now

1 Iopamidol Injection Market Overview

  • 1.1 Product Overview and Scope of Iopamidol Injection
  • 1.2 Iopamidol Injection Segment by Type
    • 1.2.1 Global Iopamidol Injection Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 9 g I/ 30 mL
    • 1.2.3 11.1 g I/ 30 mL
    • 1.2.4 Others
  • 1.3 Iopamidol Injection Segment by Application
    • 1.3.1 Global Iopamidol Injection Sales Comparison by Application: (2021-2027)
    • 1.3.2 Hospitals
    • 1.3.3 Clinics
  • 1.4 Global Iopamidol Injection Market Size Estimates and Forecasts
    • 1.4.1 Global Iopamidol Injection Revenue 2016-2027
    • 1.4.2 Global Iopamidol Injection Sales 2016-2027
    • 1.4.3 Iopamidol Injection Market Size by Region: 2016 Versus 2021 Versus 2027

2 Iopamidol Injection Market Competition by Manufacturers

  • 2.1 Global Iopamidol Injection Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Iopamidol Injection Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Iopamidol Injection Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Iopamidol Injection Manufacturing Sites, Area Served, Product Type
  • 2.5 Iopamidol Injection Market Competitive Situation and Trends
    • 2.5.1 Iopamidol Injection Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Iopamidol Injection Players Market Share by Revenue
    • 2.5.3 Global Iopamidol Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Iopamidol Injection Retrospective Market Scenario by Region

  • 3.1 Global Iopamidol Injection Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.2 Global Iopamidol Injection Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.3 North America Iopamidol Injection Market Facts & Figures by Country
    • 3.3.1 North America Iopamidol Injection Sales by Country
    • 3.3.2 North America Iopamidol Injection Revenue by Country
    • 3.3.3 United States
    • 3.3.4 Canada
  • 3.4 Europe Iopamidol Injection Market Facts & Figures by Country
    • 3.4.1 Europe Iopamidol Injection Sales by Country
    • 3.4.2 Europe Iopamidol Injection Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Iopamidol Injection Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Iopamidol Injection Sales by Region
    • 3.5.2 Asia Pacific Iopamidol Injection Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 China Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
  • 3.6 Latin America Iopamidol Injection Market Facts & Figures by Country
    • 3.6.1 Latin America Iopamidol Injection Sales by Country
    • 3.6.2 Latin America Iopamidol Injection Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
    • 3.6.6 Colombia
  • 3.7 Middle East and Africa Iopamidol Injection Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Iopamidol Injection Sales by Country
    • 3.7.2 Middle East and Africa Iopamidol Injection Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Iopamidol Injection Historic Market Analysis by Type

  • 4.1 Global Iopamidol Injection Sales Market Share by Type (2016-2021)
  • 4.2 Global Iopamidol Injection Revenue Market Share by Type (2016-2021)
  • 4.3 Global Iopamidol Injection Price by Type (2016-2021)

5 Global Iopamidol Injection Historic Market Analysis by Application

  • 5.1 Global Iopamidol Injection Sales Market Share by Application (2016-2021)
  • 5.2 Global Iopamidol Injection Revenue Market Share by Application (2016-2021)
  • 5.3 Global Iopamidol Injection Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Bracco Imaging
    • 6.1.1 Bracco Imaging Corporation Information
    • 6.1.2 Bracco Imaging Description and Business Overview
    • 6.1.3 Bracco Imaging Iopamidol Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Bracco Imaging Iopamidol Injection Product Portfolio
    • 6.1.5 Bracco Imaging Recent Developments/Updates
  • 6.2 Sanochemia
    • 6.2.1 Sanochemia Corporation Information
    • 6.2.2 Sanochemia Description and Business Overview
    • 6.2.3 Sanochemia Iopamidol Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Sanochemia Iopamidol Injection Product Portfolio
    • 6.2.5 Sanochemia Recent Developments/Updates
  • 6.3 Consentis
    • 6.3.1 Consentis Corporation Information
    • 6.3.2 Consentis Description and Business Overview
    • 6.3.3 Consentis Iopamidol Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Consentis Iopamidol Injection Product Portfolio
    • 6.3.5 Consentis Recent Developments/Updates
  • 6.4 T2Pharma
    • 6.4.1 T2Pharma Corporation Information
    • 6.4.2 T2Pharma Description and Business Overview
    • 6.4.3 T2Pharma Iopamidol Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 T2Pharma Iopamidol Injection Product Portfolio
    • 6.4.5 T2Pharma Recent Developments/Updates
  • 6.5 Bayer
    • 6.5.1 Bayer Corporation Information
    • 6.5.2 Bayer Description and Business Overview
    • 6.5.3 Bayer Iopamidol Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Bayer Iopamidol Injection Product Portfolio
    • 6.5.5 Bayer Recent Developments/Updates
  • 6.6 Takeda
    • 6.6.1 Takeda Corporation Information
    • 6.6.2 Takeda Description and Business Overview
    • 6.6.3 Takeda Iopamidol Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Takeda Iopamidol Injection Product Portfolio
    • 6.6.5 Takeda Recent Developments/Updates
  • 6.7 Fuji Pharma
    • 6.6.1 Fuji Pharma Corporation Information
    • 6.6.2 Fuji Pharma Description and Business Overview
    • 6.6.3 Fuji Pharma Iopamidol Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Fuji Pharma Iopamidol Injection Product Portfolio
    • 6.7.5 Fuji Pharma Recent Developments/Updates
  • 6.8 Hikari Pharmaceutical
    • 6.8.1 Hikari Pharmaceutical Corporation Information
    • 6.8.2 Hikari Pharmaceutical Description and Business Overview
    • 6.8.3 Hikari Pharmaceutical Iopamidol Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Hikari Pharmaceutical Iopamidol Injection Product Portfolio
    • 6.8.5 Hikari Pharmaceutical Recent Developments/Updates
  • 6.9 BeiLu Pharma
    • 6.9.1 BeiLu Pharma Corporation Information
    • 6.9.2 BeiLu Pharma Description and Business Overview
    • 6.9.3 BeiLu Pharma Iopamidol Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 BeiLu Pharma Iopamidol Injection Product Portfolio
    • 6.9.5 BeiLu Pharma Recent Developments/Updates

7 Iopamidol Injection Manufacturing Cost Analysis

  • 7.1 Iopamidol Injection Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Iopamidol Injection
  • 7.4 Iopamidol Injection Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Iopamidol Injection Distributors List
  • 8.3 Iopamidol Injection Customers

9 Iopamidol Injection Market Dynamics

  • 9.1 Iopamidol Injection Industry Trends
  • 9.2 Iopamidol Injection Growth Drivers
  • 9.3 Iopamidol Injection Market Challenges
  • 9.4 Iopamidol Injection Market Restraints

10 Global Market Forecast

  • 10.1 Iopamidol Injection Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Iopamidol Injection by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Iopamidol Injection by Type (2022-2027)
  • 10.2 Iopamidol Injection Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Iopamidol Injection by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Iopamidol Injection by Application (2022-2027)
  • 10.3 Iopamidol Injection Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Iopamidol Injection by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Iopamidol Injection by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    9 g I/ 30 mL
    11.1 g I/ 30 mL
    Others

    Segment by Application
    Hospitals
    Clinics

    By Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    China Taiwan
    Indonesia
    Thailand
    Malaysia
    Latin America
    Mexico
    Brazil
    Argentina
    Colombia
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    Bracco Imaging
    Sanochemia
    Consentis
    T2Pharma
    Bayer
    Takeda
    Fuji Pharma
    Hikari Pharmaceutical
    BeiLu Pharma

    Buy now